Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>While one may reasonably assume that more clinical research could increase the likelihood of medical breakthroughs, a contrarian&rsquo;s view is that the effect could be quite the opposite &mdash; and it falls to IRBs to intervene and reduce the risks of the current glut of trials.</p>

Clinical Trials: More is Not Necessarily Better

Amid a rising tide of research, IRBs should look for ‘social value’